Latest filing published 04 Apr 2017 for Alliqua BioMedical, Inc., €9,372.
First 200 filings with a declared amount
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Joseph M. Leone discloses dealings in 2 companies, chiefly CIT Group Inc and Alliqua BioMedical, Inc. The record holds 262 filings, for trades running from 1 February 2006 to 3 April 2017.
On the open market, the record shows 9 purchases worth €38k and 224 sales worth €12.3M. The amount is not disclosed for 4 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 21 share grants and 7 option exercises. Since January 2017: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €8,940.
The newest entry dates from 4 April 2017: an open-market purchase of €9,372, in Alliqua BioMedical, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 217 declarations